Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PRe-pOsT Interventional Study Evaluating Gardasil Nine-valent Human Papilloma Virus (HPV) Vaccine Humoral and Cellular Immune Responses in People With or Without HIV

NCT06624839 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT06624839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06624839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PRe-pOsT Interventional Study Evaluating Gardasil Nine-valent Human Papilloma Virus (HPV) Vaccine Humoral and Cellular Immune Responses in People With or Without HIV
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 2
Overall status
Recruiting
Start date
March 15, 2025
Completion date
January 31, 2028
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anal dysplasia, hiv, human papilloma virus